Skip to content

Distance and Intermediate Visual Acuity in Patients With Implanted Monofocal Negative Aspheric Intraocular Lens

Distance and Intermediate Visual Acuity in Patients With Implanted Monofocal Negative Aspheric Intraocular Lens

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05697978
Acronym
CLAINT
Enrollment
100
Registered
2023-01-26
Start date
2022-10-01
Completion date
2023-08-01
Last updated
2023-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraocular Lens

Keywords

intraocular lens, monofocal lens, intermediate visual acuity

Brief summary

To get the visual outcomes for distance and intermediate and binocular defocus curve in patients with implanted monofocal intraocular lens Clareon (IOL; model SY60CL; Alcon Vision LLC) at 3 months after the surgery.

Detailed description

The goal of refractive cataract surgery is to remove the opacity, or cataract and to produce the desired refractive outcome. In most cases, the desired outcome is an emmetropic eye, or an eye that sees 20/20 Snellen for distance vision post-surgery with the implant of a monofocal IOL. This, however, does not offer much in the way of intermediate and near vision. The increased desire for simultaneous distance, intermediate and near vision has increased the popularity of multifocal IOLs (MIOLs). However MIOLs provide visual acuity for all distances, they has occurence of optical phenomena such as glare and halo and lower contrast sensitivity. Extended depth of focus (EDOF) lens should provide distance vision as good as monofocal lens and intermediate vision better than monofocal but without or with less appearance of optical phenomenon or decreased contrast sensitivity. This study is prospective, multi-center, conducted from 10/2022 to 08/2023 in the Ophthalmology department of Faculty Hospital Kralovske Vinohrady in Prague, in Eye Center Prague and Eye Clinic SOMICH (Karlovy Vary). The research protocol was explained to all participants and informed consent was signed before enrolling patient to the study. The study was approved by the Ethics Committee of Faculty Hospital Kralovske Vinohrady and will enrolled up to 100 patients with presence of cataract in both eyes. Bilateral clear corneal phacoemulsification and IOL implantation is performed by two experienced surgeon using the same technique in both eyes. The surgical process involved topical anesthesia, superior 3-step clear corneal incision (2,2mm), 5,0mm curvilinear capsulorhexis, phacoemulsification, bilateral irrigation- aspiration and implantation of monofocal aspheric intraocular lens (Clareon Alcon vision LLC). Patients are scheduled for visit at 3 months after the surgery.

Interventions

DEVICEMonofocal intraocular lens Clareon (Alcon LLC)

monofocal aspheric lens implanted in eyes of patient during routine cataract surgery

Sponsors

Očni centrum Praha a.s.
CollaboratorUNKNOWN
Somich, s.r.o.
CollaboratorOTHER
Faculty Hospital Kralovske Vinohrady
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

no masking

Intervention model description

each patient in group received monofocal intraocular lens in both eyes

Eligibility

Sex/Gender
ALL
Age
45 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* presence of cataract in both eyes * no other ocular pathology affecting visual acuity * bilateral phacoemulsification cataract surgery was arranged for both eyes * corneal astigmatism up to 0,5 cylinder (measured by IOL Master biometry) * dioptric power of both selective lens within 1,5 D range in one patient * selecting IOL power between 15 D and 28 D power range

Exclusion criteria

* complicated cataract * corneal opacities or irregularities * amblyopia * anisometropia * coexisting ocular pathologies * glaucoma * history of ocular surgery * refusal or unable to maintain follow-up

Design outcomes

Primary

MeasureTime frameDescription
Monocular uncorrected intermediate visual acuity (UIVA)3 monthsMonocular intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm
Monocular corrected Distance Visual Acuity (CDVA)3 monthsMonocular corrected distance visual acuity (CDVA) is measured at 4 m using an ETDRS (Early Treatment Diabetic Retinopathy Study) illumination cabinet (Precision Vision) under photopic conditions.
Binocular corrected Distance Visual Acuity (CDVA)3 monthsBinocular corrected distance visual acuity (CDVA) is measured at 4 m using an ETDRS (Early Treatment Diabetic Retinopathy Study) illumination cabinet (Precision Vision) under photopic conditions.
Binocular distance corrected intermediate visual acuity (DCIVA)3 monthsBinocular distance corrected intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm
Binocular uncorrected intermediate visual acuity (UIVA)3 monthsBinocular intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm
Monocular distance corrected intermediate visual acuity (DCIVA)3 monthsMonocular distance corrected intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm

Secondary

MeasureTime frameDescription
Binocular defocus curve3 monthsA defocus curve that measures visual acuity should be obtained by using the best corrected distance refraction and then defocusing the image in 0.5 increments from +1.5 to -3.0 diopter with spherical plus and spherical minus trial lenses (i.e.,+1.5 D, +1.0 D, +0.5 D, 0.00 D, -0.5 D, -1.00 D, . . . ,-2.50 D) with visual acuity recorded at each change in correction.

Countries

Czechia

Contacts

Primary ContactAndrea Janekova, MD
janekovaandrea@gmail.com+420775727002
Backup ContactPavel Studeny, MD
StudenyPavel@seznam.cz+420775555342

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026